SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors bet on the companys pivot from crypto mining to AI-focused data center infrastructure. The community is actively discussing rumors of imminent lease contracts and positive technical momentum, with many highlighting the potential for a rerating as the company integrates into major market indices.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following the release of positive Week 52 Phase 3 trial results, which investors are positioning as a strong best-in-class indicator for their skin drug, sonelokimab. The community is actively debating the potential for an upcoming acquisition and monitoring institutional accumulation, while some retail traders express frustration over recent price volatility and the timeline for further clinical data readouts.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community interest as high volume and unusual pre-market activity fuel speculation regarding a potential buyout or upcoming catalyst for the AUR200 pipeline. Investors are closely monitoring CEO Kevin Tang's significant share accumulation while debating the impact of ongoing patent litigation and the strategic silence from the new management team.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as the market reacts to its latest acquisition of Cyberhawk, a critical infrastructure intelligence firm, alongside anticipation surrounding its upcoming inclusion in the Russell 2000 index. While the community is actively debating the company's aggressive acquisition-based growth strategy and the potential impact of its unified autonomous defense architecture, investors are closely monitoring the stock's consolidation patterns while waiting for further contract-based catalysts.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to positive topline Phase 3 data for its depression treatment, triggering significant investor interest and ongoing debate regarding its potential for commercial success against established psychedelic peers. Community discussions center on the company's clinical trial catalysts, cash runway, and the binary nature of upcoming data readouts in the competitive mental health space.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending as investors aggressively bid up memory stocks, fueled by reports of structural storage shortages and AI-driven data center demand. The community is actively debating the sustainability of this parabolic run, with some traders highlighting the stock's record-setting RSI as a sign of an overheating market while others point to institutional re-rating as evidence of a sustained supercycle.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as China implements new export controls and security reviews on critical minerals, prompting community debate over domestic supply chain independence and the effectiveness of existing government partnerships. Investors are closely monitoring how the company handles compliance and competitive pressures while weighing the broader geopolitical implications of restricted dual-use material access for the U.S. defense industrial base.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing significant selling pressure and heightened volatility, as investors weigh concerns over subscriber growth against management's capital allocation and potential M&A activity. The community remains deeply polarized, with bears aggressively betting on further downside following recent technical breaks, while bulls are scouting for value in what they consider an oversold market leader.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors capitalize on the structural AI-driven demand for HBM and storage, despite broader market volatility and uncertainty surrounding major upcoming IPOs. Community sentiment remains overwhelmingly bullish, with many participants framing the current price action as a strategic entry point for a long-term re-rating of the memory sector beyond its traditional cyclical history.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors anticipate the upcoming launch of its Phase 3 clinical trial for NSCLC, which could transform the company into a de-risked multi-asset oncology platform. Community discussion remains heavily focused on potential buyout opportunities, favorable clinical readouts, and the strategic importance of CMC validation as the company nears its BLA submission.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Plexus (PLXS) Up 6.9% Since Last Earnings Report: Can It Continue?

Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Plexus (NASDAQ:PLXS) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen raised Plexus from a "hold" rating to a "buy" rating in a research report on Saturday...

Plexus (NASDAQ:PLXS) Sets New 12-Month High on Analyst Upgrade

Plexus (NASDAQ:PLXS) Reaches New 1-Year High After Analyst Upgrade...

Here's Why Plexus (PLXS) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Plexus (NASDAQ:PLXS) Given New $285.00 Price Target at Needham & Company LLC

Needham & Company LLC upped their price target on shares of Plexus from $206.00 to $285.00 and gave the stock a "buy" rating in a research note on Friday...

Plexus Q2 Earnings Call Highlights

Plexus (NASDAQ:PLXS) reported fiscal second-quarter 2026 results that exceeded its guidance range, driven by continued program ramps, market share gains, and what management described as improving...

Plexus (NASDAQ:PLXS) Posts Quarterly Earnings Results, Beats Estimates By $0.17 EPS

Plexus (NASDAQ:PLXS - Get Free Report) posted its quarterly earnings results on Wednesday. The technology company reported $2.05 EPS for the quarter, topping the consensus estimate of $1.88 by $0.17...

Plexus' Q2 Earnings Surpass Estimates, Revenues Increase Y/Y

PLXS beats Q2 EPS estimates and posts higher revenues, fueled by strong program wins and rising demand, while boosting its fiscal 2026 growth outlook.

Plexus (PLXS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Plexus (PLXS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Plexus (PLXS) Tops Q2 Earnings and Revenue Estimates

Plexus (PLXS) delivered earnings and revenue surprises of +9.43% and +2.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Plexus Corp. engages in the provision of electronic manufacturing services. The company operates through the following geographical segments: Americas (AMER), Europe, Middle East, and Africa (EMEA), and Asia-Pacific (APAC). The company was founded by Peter Strandwitz, Shirani Ramin and John L. Nussbaum in 1979 and is headquartered in Neenah, WI.

Plexus Corp.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

PLXSPlexus Corp.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLXS News